“…The 32 publications noted in Table 1 ( Falagas and Makris, 2009 ; Manning et al, 2009 ; Kohli, 2013 ; Vandini et al, 2014a , b ; Arvanitakis, 2015 ; La Fauci et al, 2015 ; Caselli et al, 2016 ; Afinogenova et al, 2018 ; Al-Marzooq et al, 2018 , 2019 ; Caselli et al, 2018 ; D'Accolti et al, 2018 , 2019 , 2021 , 2022 , 2023 ; Rodolfi and Caselli, 2018 ; Caselli et al, 2019 ; Dural-Erem et al, 2019 ; Kleintjes et al, 2019 ; Rognoni et al, 2019 ; Caselli and Purificato, 2020 ; Kleintjes et al, 2020 ; Razenberg et al, 2020 ; Stone et al, 2020 ; Tarricone et al, 2020 ; Klassert et al, 2022 ; Soffritti et al, 2022 ; Caselli, 2023 ; Leistner et al, 2023 ; Ramos and Frantz, 2023 ) include an opinion ( Falagas and Makris, 2009 ), two patents ( Manning et al, 2009 ; Rodolfi and Caselli, 2018 ), a commentary ( Caselli and Purificato, 2020 ), a report ( Razenberg et al, 2020 ), two reviews ( D’Accolti et al, 2022 ; Ramos and Frantz, 2023 ), two book chapters ( Kohli, 2013 ; Arvanitakis, 2015 ), three conference abstracts of previously published results ( Al Marzooq et al, 2019 ; Rognoni et al, 2019 ; Caselli, 2023 ), and in vitro assays and hospital-based studies. A total of five publications assessed the efficiency of microbial-based sanitization products using in vitro assays with common healthcare-associated pathogens ( La Fauci et al, 2015 ; D'Accolti et al, 2018 , 2021 ; Dural-Erem et al, 2019 ; Stone et al, 2020 ).…”